Cargando…

VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation

Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh–like 2 (VANGL2) acts as an IFN-inducible negative feedback regulator to suppress IFN...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhiqiang, Xie, Yingchao, Lu, Jiansen, Yang, Jianwu, Zhang, Jiahuan, Jiang, Huaji, Li, Hongyu, Zhang, Yufeng, Wu, Dan, Zeng, Ke, Bai, Xiaochun, Yu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289648/
https://www.ncbi.nlm.nih.gov/pubmed/37352355
http://dx.doi.org/10.1126/sciadv.adg2339
_version_ 1785062324245102592
author Hu, Zhiqiang
Xie, Yingchao
Lu, Jiansen
Yang, Jianwu
Zhang, Jiahuan
Jiang, Huaji
Li, Hongyu
Zhang, Yufeng
Wu, Dan
Zeng, Ke
Bai, Xiaochun
Yu, Xiao
author_facet Hu, Zhiqiang
Xie, Yingchao
Lu, Jiansen
Yang, Jianwu
Zhang, Jiahuan
Jiang, Huaji
Li, Hongyu
Zhang, Yufeng
Wu, Dan
Zeng, Ke
Bai, Xiaochun
Yu, Xiao
author_sort Hu, Zhiqiang
collection PubMed
description Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh–like 2 (VANGL2) acts as an IFN-inducible negative feedback regulator to suppress IFN-I signaling during vesicular stomatitis virus (VSV) infection. Mechanistically, VANGL2 interacted with TBK1 and promoted the selective autophagic degradation of TBK1 via K48-linked polyubiquitination at Lys(372) by the E3 ligase TRIP, which serves as a recognition signal for the cargo receptor OPTN. Furthermore, myeloid-specific deletion of VANGL2 in mice showed enhanced IFN-I production against VSV infection and improved survival. In general, these findings revealed a negative feedback loop of IFN-I signaling through the VANGL2-TRIP-TBK1-OPTN axis and highlighted the cross-talk between IFN-I and autophagy in preventing viral infection. VANGL2 could be a potential clinical therapeutic target for viral infectious diseases, including COVID-19.
format Online
Article
Text
id pubmed-10289648
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-102896482023-06-24 VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation Hu, Zhiqiang Xie, Yingchao Lu, Jiansen Yang, Jianwu Zhang, Jiahuan Jiang, Huaji Li, Hongyu Zhang, Yufeng Wu, Dan Zeng, Ke Bai, Xiaochun Yu, Xiao Sci Adv Biomedicine and Life Sciences Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh–like 2 (VANGL2) acts as an IFN-inducible negative feedback regulator to suppress IFN-I signaling during vesicular stomatitis virus (VSV) infection. Mechanistically, VANGL2 interacted with TBK1 and promoted the selective autophagic degradation of TBK1 via K48-linked polyubiquitination at Lys(372) by the E3 ligase TRIP, which serves as a recognition signal for the cargo receptor OPTN. Furthermore, myeloid-specific deletion of VANGL2 in mice showed enhanced IFN-I production against VSV infection and improved survival. In general, these findings revealed a negative feedback loop of IFN-I signaling through the VANGL2-TRIP-TBK1-OPTN axis and highlighted the cross-talk between IFN-I and autophagy in preventing viral infection. VANGL2 could be a potential clinical therapeutic target for viral infectious diseases, including COVID-19. American Association for the Advancement of Science 2023-06-23 /pmc/articles/PMC10289648/ /pubmed/37352355 http://dx.doi.org/10.1126/sciadv.adg2339 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Hu, Zhiqiang
Xie, Yingchao
Lu, Jiansen
Yang, Jianwu
Zhang, Jiahuan
Jiang, Huaji
Li, Hongyu
Zhang, Yufeng
Wu, Dan
Zeng, Ke
Bai, Xiaochun
Yu, Xiao
VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
title VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
title_full VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
title_fullStr VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
title_full_unstemmed VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
title_short VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
title_sort vangl2 inhibits antiviral ifn-i signaling by targeting tbk1 for autophagic degradation
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289648/
https://www.ncbi.nlm.nih.gov/pubmed/37352355
http://dx.doi.org/10.1126/sciadv.adg2339
work_keys_str_mv AT huzhiqiang vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT xieyingchao vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT lujiansen vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT yangjianwu vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT zhangjiahuan vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT jianghuaji vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT lihongyu vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT zhangyufeng vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT wudan vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT zengke vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT baixiaochun vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation
AT yuxiao vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation